High CSF Neurogranin Associated With Faster Decline in Mild Cognitive Impairment


Investigators obtained data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database on patients with normal cognition (n=111) and MCI (n=193), all of whom had CSF Ng samples at baseline as well as memory and executive function evaluations at follow-up.